Constitutive Activation of JAKs and STATs in BCR-Abl-Expressing Cell Lines and Peripheral Blood Cells Derived from Leukemic Patients

Journal of Immunology

Volumn 159, Issue 10, 1997, Pages 4720-4728

  Chai, Sylvia K ^a   Nichols, Gwen L ^a   Rothman, Paul ^a,b  

^a The New York Presbyterian Hospital   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; DNA BINDING PROTEIN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; MILK PROTEIN; PROTEIN TYROSINE KINASE; STAT1 PROTEIN; STAT1 PROTEIN, HUMAN; STAT1 PROTEIN, MOUSE; STAT5 PROTEIN; TRANSACTIVATOR PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL; ARTICLE; BIOSYNTHESIS; BLOOD; CELL CULTURE; CHRONIC MYELOID LEUKEMIA; DRUG ANTAGONISM; ENZYME ACTIVATION; ENZYMOLOGY; HUMAN; METABOLISM; MOUSE; MYELOID LEUKEMIA; SIGNAL TRANSDUCTION;

ANIMALS; DNA-BINDING PROTEINS; ENZYME ACTIVATION; FUSION PROTEINS, BCR-ABL; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERFERON TYPE II; INTERLEUKIN-3; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; MICE; MILK PROTEINS; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT5 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED;

EID: 0031573141     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Rowley, J. D. 1973. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243:290.
2. Laneuville, P. 1995. Abl tyrosine protein kinase. Semin. Immunol. 7:255.
3. Laneuville, P., N. Heisterkamp, and J. Groffen. 1991. Expression of the chronic myelogenous leukemia-associated p210bcr/abl oncoprotein in a murine IL-3 dependent myeloid cell line. Oncogene 6:275.
4. Hariharan, I. K., J. M. Adams, and S. Cory. 1988. bcr-abl oncogene renders myeloid cell line factor independent: potential autocrine mechanism in chronic myeloid leukemia. Oncogene Res. 3:387.
5. bcr/abl protein. Proc. Natl. Acad. Sci. USA 85:9312.
6. McLaughlin, J., E. Chianese, and O. N. Witte. 1987. In vitro transformation immature hematopoietic cells by the p210 BCR/ABL oncogene product of the Philadelphia chromosome. Proc. Natl. Acad. Sci. USA 84:6558.
7. Young, J. C., and O. N. Witte. 1988. Selective transformation of primitive lymphoid cells by the BCR/ABL oncogene expressed in long-term lymphoid or myeloid cultures. Mol. Cell. Biol. 8:4079.
8. Kawano, M., T. Hirano, T. Matsuda, T. Taga, Y. Horii, K. Iwato, H. Asaoku, B. Tang, O. Tanabe, and H. Tanaka. 1988. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 332:83.
9. Portier, M., G. Rajzbaum, X. G. Zhang, M. Attal, C. Rusalen, J. Wijdenes, P. Mannoni, D. Maraninchi, M. Piechaczyk, and R. Bataille. 1991. In vivo interleukin 6 gene expression in the tumoral environment in multiple myeloma. Eur. J. Immunol. 21:1759.
10. Kawano, M., A. Kuramoto, T. Hirano, and T. Kishimoto. 1989. Cytokines as autocrine growth factors in malignancies. Cancer Surv. 8:905.
11. Sirard, C., P. Laneuville, and J. E. Dick. 1994. Expression of bcr-abl abrogates factor-dependent growth of human hematopoietic M07E cells by an autocrine mechanism. Blood 83:1575.
12. Anderson, S. M., and J. Mladenovic. 1996. The BCR-ABL oncogene requires both kinase activity and src-homology 2 domain to induce cytokine secretion. Blood 87:238.
13. Harrison, D. A., R. Binari, T. S. Nahreini, M. Gilman, and N. Perrimon. 1995. Activation of a Drosophila Janus kinase (JAK) causes hematopoietic neoplasia and developmental defects. EMBO J. 14:2857.
14. Migone, T. S., J.-X. Lin, A. Cereseto, J. C. Mulloy, J. J. O'Shea, G. Franchini, and W. J. Leonard. 1995. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-1. Science 269:79.
15. Cao, X., A. Tay, G. R. Guy, and Y. H. Tan. 1996. Activation and association of Stat3 with Src in v-Src-transformed cell lines. Mol. Cell. Biol. 16:1595.
16. Danial, N. N., A. Pernis, and P. B. Rothman. 1995. Jak-STAT signaling induced by the v-abl oncogene. Science 269:1875.
17. Shuai, K., J. Halpern, J. ten Hoeve, X. Rao, and C. L. Sawyers. 1996. Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia. Oncogene 13:247.
18. Carlesso, N., D. A. Frank, and J. D. Griffin. 1995. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl. J. Exp. Med 183:811.
19. Ilaria, R. L., Jr., and R. A. Van Etten. 1996. P210 and p190 BCR/ABL induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members. J. Biol. Chem. 271:31704.
20. Dusanter-Fourt, I., A. Ahmed, T. Bennardo, C. Issad, B. Varet, W. Vainchenker, and A. G. Turhan. 1995. BCR-Abl p210 and p190 induce constitutive activation of Stat5 in human and murine factor-dependent cell lines. Blood 86:166a.
21. Wilson-Rawls, J., S. Xie, J. Liu, P. Laneuville, and R. B. Arlinghaus. 1996. P210 Bcr-Abl interacts with the interleukin 3 receptor beta-c subunit and constitutively induces its tyrosine phosphorylation. Cancer Res. 56:3426.
22. Gouilleux-Gruart, V., F. Gouilleux, C. Desaint, J. F. Claisse, J. F. Capiod, J. Delober, R. Weber-Nordt, I. Dusante-Fourt, F. Dreyfus, B. Groner, and L. Prin. 1996. STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients. Blood 87:1692.
23. Kanwar, V. S., B. Witthuhn, D. Campana, and J. N. Ihle. 1996. Lack of constitutive activation of Janus kinases and signal transduction and activation of transcription factors in Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 87:4911 (Lett.).
24. Kitamura, T., A. Tojo, T. Kuwaki, S. Chiba, K. Miyazono, A. Urabe, and F. Takaku. 1989. Identification and analysis of human erythropoietin receptors on a factor-dependent cell line, TF-1. Blood 73:375.
25. Kitamura, T., T. Tange, T. Terasawa, S. Chiba, T. Kuwaki, K. Miyagawa, Y. F. Piao, K. Miyazono, A. Urabe, and F. Takaku. 1989. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J. Cell. Physiol. 140:323.
26. Huhn, R. D., M. R. Posner, S. I. Rayter, J. G. Foulkes, and A. R. Frackelton, Jr. 1987. Cell lines and peripheral blood leukocytes derived from individuals with chronic myelogenous leukemia display virtually identical proteins phosphorylated on tyrosine residues. Proc. Natl. Acad. Sci. USA 84:4408.
27. Lozzio, C. B., and B. B. Lozzio. 1975. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 45:321.
28. Nitta, M., Y. Kato, A. Strife, M. Wachter, J. Fried, A. Perez, S. Jhanwar, R. Duigou-Osterndorf, R. S. K. Chaganti, and B. Clarkson. 1985. Incidence of involvement of the B and T lymphocyte lineages in chronic myelogenous leukemia. Blood 66:1053.
29. Siegel, J. P., and H. S. Mostowski. 1990. A bioassay for the measurement of human interleukin-4. J. Immunol. Methods 132:287.
30. Mannick, J. B., J. I. Cohen, M. Birkenbach, A. Marchini, and E. Kieff. 1991. The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation. J. Virol. 65:6826.
31. Mannick, J. B., K. Asano, K. Izumi, E. Kieff, and J. S. Stamler. 1994. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell 79:1137.
32. Klein, G., L. Dombos, and B. Gothoskar. 1972. Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus. Int. J. Cancer 10:44.
33. Alt, F. W., N. Rosenberg, R. Casanova, E. Thomas, and D. Baltimore. 1982. Immunoglobulin heavy chain expression and class-switching in a murine leukemia cell line. Nature 296:325.
34. Goga, A., J. McLaughlin, D. E. Afar, D. C. Saffran, and O. N. Witte. 1995. Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene. Cell 82:981.
35. Pine, R., A. Canova, and C. Schindler. 1994. Tyrosine phosphorylated p91 binds to a single element in the ISGF2/IRF-1 promoter to mediate induction by IFN alpha and IFN gamma, and is likely to autoregulate the p91 gene. EMBO J. 13:158.
36. Bonni, A., D. A. Frank, C. Schindler, and M. E. Greenberg. 1992. Characterization of a pathway for ciliary neurotropic factor signaling to the nucleus. Science 262:1575.
37. Eilers, A., D. Seegert, C. Schindler, M. Baccarini, and T. Decker. 1993. The response of gamma interferon activation factor is under developmental control in cells of the macrophage lineage. Mol. Cell. Biol. 13:3245.
38. Schindler, C., K. Shuai, V. R. Prezioso, and J. E. Darnell, Jr. 1992. Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science 257:809.
39. Schindler, C., X. Y. Fu, T. Improta, R. Aebersold, and J. Darnell, Jr. 1992. a. Proteins of transcription factor ISGF-3: one gene encodes the 91- and 84-kDa ISGF-3 proteins that are activated by interferon alpha. Proc. Natl. Acad. Sci. USA 89:7836.
40. Rothman, P., B. Kreider, M. Azam, D. Levy, U. Wegenka, A. Eilers, T. Decker, F. Horn, H. Kashleva, J. Ihle, and C. Schindler. 1994. Cytokines and growth factors signal through tyrosine phosphorylation of a family of related transcription factors. Immunity 1:457.
41. Pernis, A., S. Gupta, J. Yopp, E. Garfein, H. Kashleva, C. Schindler, and P. Rothman. 1995. Gamma chain-associated cytokine receptors signal through distinct transducing factors. J. Biol. Chem. 270:14517.
42. Keegan, A. D., K. Nelms, M. White, L. M. Wang, J. H. Pierce, and W. E. Paul. 1994. An IL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-1 phosphorylation and cell growth. Cell 76:811.
43. Johnston, J. A., M. Kawamura, R. A. Kirken, Y. Q. Chen, T. B. Blake, K. Shibuya, J. R. Ortaldo, D. W. McVicar, and J. J. O'Shea. 1994. Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2. Nature 370:151.
44. Wang, L. M., A. D. Keegan, W. E. Paul, M. A. Heidaran, J. S. Gutkind, and J. H. Pierce. 1992. IL-4 activates a distinct signal transduction cascade from IL-3 in factor-dependent myeloid cells. EMBO J 11:4899.
45. Wang, L. M., A. D. Keegan, W. Li, G. E. Lienhard, S. Pacini, J. S. Gutkind, M. G. Myers, Jr., X. J. Sun, M. F. White, and S. A. Aaronson. 1993. Common elements in interleukin 4 and insulin signaling pathways in factor-dependent hemalopoietic cells. Proc. Natl. Acad. Sci. USA 90:4032.
46. Yu-Lee, L. Y., J. A. Hrachovy, A. M. Stevens, and L. A. Schwarz. 1990. Interferon-regulatory factor 1 is an immediate-early gene under transcriptional regulation by prolactin in Nb2 T cells. Mol. Cell. Biol. 10:3087.
47. Yuan, J., U. M. Wegenka, C. Lutticken, J. Buschmann, T. Decker, C. Schindler, P. C. Heinrich, and F. Horn. 1994. The signalling pathways of interleukin-6 and gamma Interferon converge by the activation of different transcription factors which bind to common responsive DNA elements. Mol. Cell. Biol. 14:1657.
48. Mui, A. L., H. Wakao, N. Harada, A. M. O'Farrell, and A. Miyajima. 1995. Interleukin-3, granulocyte-macrophage colony-stimulating factor, and interleukin-5 transduce signals through two forms of STAT5. J. Leukocyte Biol. 57:799.
49. Mui, A. L., H. Wakao, A. M. O'Farrell, N. Harada, and A. Miyajima. 1995. Interleukin-3. granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STAT5 homologs. EMBO J. 14:1166.
50. Azam, M., H. Erdjument-Bromage, B. L. Kreider, M. Xia, F. Quelle, R. Basu, C. Saris, P. Tempst, J. N. Ihle, and C. Schindler. 1995. Interleukin-3 signals through multiple isoforms of StatS. EMBO J. 14:1402.
51. Meydan, N., T. Grunberger, H. Dadi, M. Shahar, E. Arpaia, Z. Lapidot, J. S. Leeder, M. Freedman, A. Cohen, A. Gazit, A. Levitzki, and C. M. Roifman. 1996. Inhibition of acute lymphoblastic leukaemia by a JAK-2 inhibitor. Nature 379:645.
52. Stahl, N., T. J. Farrugella, T. G. Boulton, Z. Zhong, J. E. Darnell, Jr., and G. D. Yancopoulos. 1995. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 267:1349.
53. Heim, M. H., I. M. Kerr, G. R. Stark, and J. E. Darnell, Jr. 1995. Contribution of STAT SH2 groups to specific interferon signaling by the Jak-STAT pathway. Science 267:1347.
54. Rosenberg, N. 1994. Abl-mediated transformation, immunoglobulin gene rearrangements and arrest of B lymphocyte differentiation. Semin. Cancer Biol. 5:95.
55. Lugo, T. G., A. Pendergast, A. J. Muller, and O. N. Witte. 1990. Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science 247: 1079.
56. Ilaria, R. L., Jr., and R. A. Van Etten. 1995. The SH2 domain of P210 BCR/ABL is not required for the transformation of hematopoietic factor-dependent cells. Blood 86:3897.
57. Pernis, A., S. Gupta, J. Yopp, E. Garfein, H. Kashleva, C. Schindler, and P. Rothman. 1995. Gamma chain-associated cytokine receptors signal through distinct transducing factors. J. Biol. Chem. 270:14517.